Iron: Oxygen Transport, Electron Transfer, and DNA Synthesis

Core Idea

Iron serves critical roles as the oxygen-binding prosthetic group in hemoglobin and myoglobin, and as an enzymatic cofactor in cytochrome oxidase, catalase, peroxidase, and ribonucleotide reductase. Iron deficiency impairs oxygen delivery, energy production, and DNA synthesis, causing fatigue, infections, and developmental delays. Iron absorption and storage are tightly regulated through hepcidin to maintain homeostasis, as the body has limited excretion mechanisms.

Explainer

Iron is one of those nutrients whose essentiality is easy to understate — it does far more than carry oxygen. You likely know from your study of hemoglobin dynamics that iron sits at the center of the heme group, held in a ferrous (Fe²⁺) state and able to reversibly bind O₂. This reversibility is the key: iron can accept and donate electrons without being permanently oxidized, making it uniquely suited as a redox cofactor. The same chemical property that makes iron useful in hemoglobin also makes it indispensable in the mitochondrial electron transport chain, where cytochrome oxidase (Complex IV) uses iron-containing heme groups to transfer electrons to oxygen, the final acceptor in aerobic respiration.

Hemoglobin and myoglobin are the most familiar iron-containing proteins. Hemoglobin, with four heme groups per molecule, picks up oxygen in the lungs where PO₂ is high and releases it in tissues where PO₂ is low. Myoglobin, found in muscle, has a single heme group and a higher oxygen affinity; it acts as an oxygen reservoir, releasing O₂ only when intramuscular PO₂ drops very low during intense exercise. Both rely entirely on iron in the Fe²⁺ state — oxidation to Fe³⁺ (methemoglobin) abolishes oxygen binding entirely. Iron's role in the electron transport chain extends this principle: the cytochromes are heme proteins that shuttle electrons down the chain, and without adequate iron the entire energy production machinery slows.

Iron's role in DNA synthesis is less intuitive but equally critical. Ribonucleotide reductase, the enzyme that converts ribonucleotides to deoxyribonucleotides (the building blocks of DNA), requires an iron-containing tyrosyl radical in its active site. Without adequate iron, this enzyme stalls, and rapidly dividing cells — immune cells, red blood cell precursors, intestinal epithelium — cannot replicate their DNA. This is why iron deficiency doesn't just cause anemia; it also impairs immune function and developmental growth. Catalase and peroxidases, both iron-containing enzymes, protect cells from oxidative damage, so iron deficiency also reduces antioxidant capacity.

The body responds to iron's indispensability by tightly regulating it through hepcidin, a liver-derived peptide that controls the iron exporter ferroportin on intestinal enterocytes and macrophages. When iron stores are adequate, hepcidin levels rise, ferroportin is degraded, and iron absorption is suppressed. When stores are depleted, hepcidin falls and absorption increases. Because the body has almost no active iron excretion mechanism — iron leaves mainly through blood loss and shed epithelial cells — this input-side regulation is the primary homeostatic control. The practical consequence is that iron deficiency depletes in stages: ferritin (stored iron) falls first, before serum iron and transferrin saturation decline, and long before hemoglobin drops into the anemic range. You can be functionally iron-deficient in enzyme activity while still appearing hematologically normal, which is why comprehensive assessment (ferritin + transferrin saturation + hemoglobin) gives a truer picture of iron status than any single marker alone.